Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences

Group 1 - Akoya Biosciences, Inc. will release its financial results for Q2 2024 on August 5, 2024, after market close [1] - A conference call to discuss the financial results will be held at 5:00 p.m. ET on the same day [1] - Investors must register online to listen to the conference call, with a recommendation to register at least a day in advance [1] Group 2 - Akoya will participate in two upcoming investor conferences: Canaccord Genuity 44th Annual Growth Conference on August 13, 2024, and Morgan Stanley 22nd Annual Global Healthcare Conference on September 6, 2024 [1] - Live and archived webcasts of these events will be available on the Akoya website [1] Group 3 - Akoya Biosciences focuses on spatial phenotyping to enhance understanding of biology and human health [2] - The company provides comprehensive single-cell imaging solutions, including PhenoCode™ Panels, PhenoCycler®, PhenoImager® Fusion, and PhenoImager HT Instruments [2] - Akoya aims to meet the diverse needs of researchers across discovery, translational, and clinical research [2]